Science updates: Nosema and honey bees

 

Science updates:

Nosema and honey bees

 

The research article titled "Production, Characterization and Therapeutic Efficacy of Egg Yolk Antibodies Specific to Nosema ceranae" published in PLOS ONE presents a study on the development of alternative prophylactic and curative strategies for the treatment of Nosema disease in honey bees. The study aimed to investigate the therapeutic potential of specific egg yolk immunoglobulins (IgY) on Nosema disease caused by Nosema ceranae, a single-celled fungal microsporidian parasite. The research involved the production of IgY antibodies from chicken egg yolks through vaccination with live and inactivated vaccines derived from N. ceranae. The IgY extraction and purification were performed, and the presence of N. ceranae-specific IgYs was investigated using Western Blot and indirect ELISA methods.

 

The study found that specific IgYs showed high therapeutic efficacy on Nosema disease in naturally infected bee colonies. Furthermore, the effectiveness of IgYs was investigated under controlled conditions, which demonstrated a significant reduction in the Nosema spore load and the number of infected bees. The findings suggest that chicken IgYs have the potential for use as an alternative to antifungal drugs in treating Nosema disease in honey bees, providing an innovative and eco-friendly method.

 

 

The study addresses the urgent need for alternative prophylactic and curative strategies for Nosema disease in honey bees, given the limitations and potential toxic threats associated with existing treatments such as fumagillin. By investigating the therapeutic potential of specific egg yolk immunoglobulins (IgY) on Nosema disease, the research provides valuable insights into the potential use of chicken IgYs as an alternative to antifungal drugs. The study involved the production, characterization, and investigation of the therapeutic efficacy of specific IgYs on Nosema disease in both naturally infected bee colonies and under controlled conditions. The findings revealed high therapeutic efficacy of specific IgYs in reducing the Nosema spore load and the number of infected bees, indicating their potential as an alternative and eco-friendly method for treating Nosema disease.

 

 

In conclusion, the study contributes to the development of innovative and eco-friendly treatment methods for Nosema disease in honey bees. The successful production and characterization of N. ceranae-specific IgY antibodies from chicken egg yolks, combined with the demonstrated therapeutic efficacy in reducing the Nosema spore load and the number of infected bees, highlight the potential of chicken IgYs as an alternative to antifungal drugs for the treatment of Nosema disease. This research provides a significant advancement in addressing the challenges associated with existing treatments and offers a promising alternative approach for managing Nosema disease in honey bees.

 

 

Reference:

Açık, M. N., Karagülle, B., Yakut, S., Öztürk, Y., Kutlu, M. A., Kalın, R., & Çetinkaya, B. (2024). Production, characterization and therapeutic efficacy of egg yolk antibodies specific to Nosema ceranae. Plos one, 19(2), e0297864.

 

 

                                    ******////////////**********